Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 11, 2000 - Issue 3
Submit an article Journal homepage
27
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Treatment of polymorphic light eruption

TP Millard Department of Photobiology, Institute of Dermatology, St Thomas’ Hospital, London, UK
,
JLM Hawk Department of Photobiology, Institute of Dermatology, St Thomas’ Hospital, London, UK
,
LB Travis State University of New York Health Science Center, Brooklyn, New York, USA
&
JM McGregor Department of Photobiology, Institute of Dermatology, St Thomas’ Hospital, London, UK
Pages 195-199 | Published online: 12 Jul 2009

  • Pao C, Norris PG, Corbett M, Hawk JL. Polymorphic light eruption: prevalence in Australia and England. Br J Dermatol 1994) 130:62-4.
  • Norris PG, Hawk JL. The acute idiopathic photodermatoses. Semin Dermotel (1990) 9: 32-8.
  • Rhodes LE, Topical and systemic approaches for protection against solar radiation-induced skin damage. Clin Dermatol (1998) 16:75-82.
  • Diffey BL, Ultraviolet radiation and human health. Clin Dermatol (1998) 16:83-9.
  • Azurdia RM, Pagliaro JA, Diffey BL, Rhodes LE, Sunscreen application by photosensitive patients is inadequate for protection.Br J Dermatol 1999) 140: 255-8.
  • Proby CM, Baker CS, Morton O, Hawk JL, New broad-spectrum sunscreen for polymorphic light eruption. Lancet (1993) 341: 1347-8.
  • Honigsmann H, Effect of therapeutic sunscreen cream on phototest reaction in polymorphic light dermatosis. Z Haukr (1989) 64:1065-8.
  • Man I, Dawe RS, Ferguson J, Artificial hardening for polymorphic light eruption: practical points from ten years' experience. Photodermatol Photoimmunol Photomed ( 1999) 15:96-9.
  • Norris PG, Barker JN, Alien MH et al, Adhesion molecule expression in polymorphic light eruption. J Invest Dermatol (1992) 99: 504-8.
  • Honigsmann H, Psoralen photochemotherapy - mechanisms, drugs, toxicity. Curr P r obi Dermatol (1986) 15: 52-66.
  • Van der Leun JC, van Weelden H, UVB phototherapy: principles, radiation sources, regimens. Curr Probl Dermatol (1986) 15: 39-51.
  • Ortel B, Tanew A, Wolff K, Honigsmann H, Polymorphous light eruption: action spectrum and photoprotection. / Am Acad Dermatol (1986) 14: 748-53.
  • Murphy GM, Logan RA, Lovell CR et al, Prophylactic PUVA and UVB therapy in polymorphic light eruption - a controlled trial. Br J Dermatol 1987) 116: 531-8.
  • Addo HA, Sharma SC, UVB phototherapy and photochemotherapy (PUVA) in the treatment of polymorphic light eruption and solar urticaria. Br J Dermatol (1987) 116: 539-47.
  • Bilsland D, George SA, Gibbs NK et al, A comparison of narrow band phototherapy (TL-Ol) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol (1993) 129: 708-12.
  • Menagé H du P, Norris PG, Cheong WK, Short course of PUVA therapy is effective in polymorphic light eruption. Br J Dermatol (1992) 127(suppl 40): 32.
  • Berg M, Ros AM, Berne B, Ultraviolet A phototherapy and trimethylpsoralen UVA photochemotherapy in polymorphous light eruption - a controlled study. Photodermatol Photoimmunol Photomed( 1994) 10: 139-43.
  • Young AR, Carcinogenicity of UVB phototherapy assessed. lancet (1995) 345: 1431-2.
  • Anonymous, British Photodermatology Group guidelines for PUVA. Br] Dermatol (1994) 130: 246-55.
  • Parrish JA, Levine MJ, Morison WL et al, Comparison of PUVA and beta-carotene in the treatment of polymorphous light eruption. Br J Dermatol (1979) 100:187-91.
  • Plewig G, Holzle K. Lehmann P, Phototherapy for photodermatoses. Curr Probl Dermatol (1986) IS: 254-64.
  • Morison WL, Momtaz K, Mosher DB. Parrish JA. UV-B phototherapy in the prophylaxis of polymorphous light eruption. Br J Dermatol(1982) 106:231-3.
  • Mastalier U, Kerl H, Wolf P, Clinical, laboratory, phototest and phototherapy findings in polymorphic light eruptions: a retrospective study of 133 patients. Eur J Dermatol (1998) 8: 554-9.
  • Gschnait F, Schwarz T, Ladich I, Treatment of polymorphous light eruption. Arch Dermatol Res (1983) 275: 379-82.
  • Molin L, Volden G, Treatment of polymorphous light eruption with PUVA and prednisolone. Photo-Drematol (1987) 4:107-8.
  • Creamer D, Patel D, Bellamy G et al. Assessment of the efficacy of a short course of oral prednisolone in the treatment of polymorphic light eruption. Br J Dermatol (1999) 141 (suppl 55): 74.
  • Norris PG. Hawk JL. Successful treatment of severe polymorphous light eruption with azathioprine. Arch Dermatol (1989) 125:1377-9.
  • Corbett MK. Hawk JL, Herxheimer A, Magnus IA. Controlled therapeutic trials in polymorphic light eruption. Br J Dermatol (1982) 107: 571-8l.
  • Murphy GM. Hawk JL, Magnus IA. Hydroxychloroquine in polymorphic light eruption: a controlled trial with drug and visual sensitivity monitoring. Br J Dermatol (1987) 116: 379-86.
  • Neumann R, Rappold E, Pohl-Markl H. Treatment of polymorphous light eruption with nicotinamide: a pilot study. Br J Dermatol (1986) 115: 77-80.
  • Ortel B, Wechdorn D, Tanew A, Honigsmann H. Effect of nicotinamide on the phototest reaction in polymorphous light eruption. Br J Dermatol (1988) 118:669-73.
  • Swanbeck G, Wennersten G, Treatment of polymorphous light eruptions with beta-carotene. Acta Denn Venereal (1972) 52:462-6.
  • Mathews-Roth MM. Carotenoids in erythropoietic protoporphyria and other photosensitivity diseases. Ann NY Acad Sri (1993) 691: 127-38.
  • Jansen CT. Oral carotenoid treatment in polymorphous light eruption: a cross-over comparison with oxychloroquine and placebo. Photo-Dermatol (1985) 2: 166-9.
  • Rhodes LE, Durham BH. Fraser WD. Friedmann PS. Dietary fish oil reduces basal and ultraviolet B-generated PGE2 levels in skin and increases the threshold to provocation of polymorphic light eruption. J invest Dermatol (1995) 105: 532-5.
  • Hadshiew I, Stab F, Untiedt S et al. Effects of topically applied antioxidants in experimentally provoked polymorphous light eruption. Dermatology 1997) 195: 362-8.
  • Creamer D. McGregor JM. Hawk JL, Polymorphic light eruption occurring in common variable hypogammaglobulinaemia, and resolving with intravenous immunoglobulin therapy. Clin Exp Dermatol (1999) 24: 273-4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.